2021 Global Year Webinar
IASP is offering a webinar series as part of its 2021 Global Year About Back Pain. Webinars will be scheduled and added to this list on a regular basis. Check back often to see when new information is added. All webinars are free for IASP members. Some webinars indicated with an asterisk (*) have a fee for non-members.
Length: 90 minutes
Resilience is characterized by the ability to successfully adapt to stressful events in the face of adverse conditions. Although evidence suggests that resilient individuals demonstrate the ability to effectively cope with a crisis or adversity while maintaining positive emotional and physical functioning, limited research has considered the role of positive, psychological resources in promoting pain resilience. During this webinar, Dr. Goodin will highlight emerging research on individual factors of resilience that diminish the severity of chronic low back pain and related disability and discuss these findings in terms of future directions for pain management. Dr. Day will discuss the need to move towards personalizing evidence-based treatment approaches, and to consider not just does an intervention “work” for a given pain condition, but is it well suited for a given individual to address their coping deficits and to enhance inherent strengths. Theory and data will be presented from a low back pain trial on the heterogeneity of treatment responses and will suggest pathways for moving towards precision medicine and patienttreatment matching algorithms. Finally, Dr. Bartley will highlight treatment approaches that promote resilience and improve pain coping, including data from a recent group-based clinical trial aimed at enhancing psychological resilience among older adults with chronic low back pain.
Emily Bartley, PhD, University of Florida, United States
Dr. Bartley is an Assistant Professor in the Department of Community Dentistry and Behavioral Science, Pain Research & Intervention Center of Excellence (PRICE), at the University of Florida. She received her PhD in clinical psychology from the University of Tulsa, followed by a postdoctoral fellowship in translational pain research from the University of Florida. Dr. Bartley’s research program targets the assessment of biological and psychosocial factors that impact chronic pain and how these mechanisms affect patient response to intervention. She is particularly focused on examining adaptive processes that foster resilience in pain, with an emphasis on the development of targeted clinical interventions that promote resilience, goal-directed behavior, and positive health. Her work in the area of low back pain and resilience is currently supported by grants from the Claude D. Pepper Older Americans Independence Center (Pain Resilience and Inflammatory Marker Expression, PRIME), NIH/NIA Research Centers Collaborative Network (Protective Resilience Index for Successful Aging in Musculoskeletal Pain, PRISM), and an NIH/NIA R00 (Adaptability and Resilience in Aging Adults, ARIAA) and NIH/NIA R21 (Empowering the Management of Pain-Obesity-Weight through Enhanced Reward, EMPOWER).
Burel Goodin, PhD, The University of Alabama at Birmingham, United States
Dr. Goodin is an Associate Professor of Psychology and Co-Director of the newly developed UAB Center for Addiction & Pain Prevention & Intervention (CAPPI) Dr. Goodin has a significant amount of experience in musculoskeletal pain and disparities research, including a strong track record of mentoring beginning clinician scientists in patient-oriented research. His program of research includes studies designed to identify biopsychosocial mechanisms contributing to clinical and experimental pain responses, and more recently, studies examining the intersection of pain and substance use disorders. For more than 10 years, his research has used quantitative sensory testing to characterize the functioning of the pain processing system in healthy individuals and in people with clinical pain conditions. He currently serves as the PI of the Examining Racial and SocioEconomic Disparities (ERASED) in Low Back Pain Study (R01MD010441) and the site PI of the Pain Relief for Osteoarthritis through Combined Treatments (PROACT) study (R37AG033906; PI: Roger Fillingim). Additionally, Dr. Goodin is also the PI of the HIV Insomnia Pain Physical function and Inflammation (HIPPI) study (R01HL147603), a laboratory-based study designed to examine whether insomnia drives inflammation, as well as experimental and clinical pain reports in people living with HIV.
Melissa Day, PhD, The University of Queensland, Australia
Dr. Day completed her M.A. and Ph.D. in Clinical Health Psychology and post-doctoral research fellowship in pain psychology at the University of Washington. She is now an endorsed Clinical Psychologist and Health Psychologist in Australia and works as an Associate Professor in the School of Psychology at The University of Queensland. Dr. Day’s program of research has focused on implementing randomized controlled trials to evaluate the efficacy and mechanisms of cognitive-behavioral and mindfulness-based interventions for chronic pain conditions. She recently published a sole authored book with Wiley titled, “Mindfulness-Based Cognitive Therapy for Chronic Pain: A Clinical Manual and Guide”.
Kimberly Sibille, PhD, MA, University of Florida, United States
Dr. Sibille is an Associate Professor in the Departments of Physical Medicine & Rehabilitation and Anesthesiology, Division of Pain Medicine in the College of Medicine at the University of Florida and the Director of the Pain TRAIL, Translational Research in Assessment and Intervention Lab. She has a background in exercise science, a Master’s degree in Counselor Education, a Doctoral degree in Psychology/Clinical Psychology with concentrations in Neuropsychology and Health Psychology, and Post-Doctoral training in Clinical/Translational Pain Research. Her research efforts are specific to investigating the biological interface of chronic pain, resilience, and factors contributing to health disparities. Based on an established physiological model, her lab has developed a pain phenotyping measure, Chronic Pain Stage, with findings spanning biological, cognitive, and physical functioning. Additionally, research is underway on a pain resilience index that is biologically predictive and clinically applicable. She is currently funded by the National Institute on Aging and the National Institute of Mental Health. Previous funding includes the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the American Pain Society, the International Association for the Study of Pain, and the University of Florida Clinical and Translational Science Institute. Her research aspirations are to increase understanding of the biological interface of chronic pain and associated factors; to formulate a clinical composite for assessing and evaluating treatment interventions; and to identify strategies and targets to prevent, reduce or ameliorate chronic pain and enhance functioning.